Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV) (NIPPV)

3 december 2014 uppdaterad av: McMaster University

Efficacy and Safety of NIPPV to Increase Survival Without Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants

The machines and oxygen used to help very premature babies breathe can have side-effects, such as bronchopulmonary dysplasia (BPD). Infants with BPD get more complications (a higher death rate, a longer time in intensive care and on assisted ventilation, more hospital readmissions in the first year of life, and more learning problems) than infants who do not develop BPD. Doctors try to remove the tube in the wind-pipe that links the baby to the breathing machine as soon as possible. However, small babies get tired, and still require help to breathe. One of the standard and common techniques to help them breathe without a tube in the wind-pipe is to use simple pressure support, nasal continuous positive airway pressure or nCPAP. This supports breathing a little, but it is often not enough to prevent the need to go back on the breathing machine.

Nasal intermittent positive pressure ventilation (NIPPV) is similar to nCPAP, but also gives some breaths, or extra support, to babies through a small tube in the nose. NIPPV is safe and effective, and already in use as an alternate "standard" therapy.

The main research question: After being weaned from the breathing machine, is NIPPV better than nCPAP in preventing BPD in premature babies weighing 999 grams or less at birth?

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

The immature lung of extremely low birth weight (ELBW, < 1000 g) infants is easily damaged by the placement of an endotracheal tube to deliver mechanical ventilation and oxygen. This and the total time of mechanical ventilation contributes to bronchopulmonary dysplasia (BPD). Infants with BPD have an increased risk of later death or neuro-impairment. With the increasing survival of ELBW infants in the NICU, there has been a proportionate increase in the number of infants surviving with BPD.

Following invasive ventilation via an endotracheal tube (ETT), extubation to nasal Continuous Positive Airway Pressure (nCPAP)ventilation is the standard approach. Currently, 40% of infants who are extubated and given nCPAP support fail, and require re-intubation. Previous work suggests that a less invasive respiratory support such as Nasal Intermittent Positive Pressure Ventilation (NIPPV), without an endotracheal tube is less injurious to the lung. NIPPV may thereby reduce the duration of invasive ventilator support, and aid successful early extubation. We hypothesize that the use of NIPPV leads to a higher rate of survival without BPD than standard therapy with nCPAP.

This randomized clinical trial is appropriately powered to compare NIPPV with nCPAP to detect effects on clinically relevant long-term outcomes, such as death and BPD at 36 weeks. This is a multi-national, randomized, open clinical trial of two different standard methods of providing non-invasive respiratory support to 1000 extremely preterm infants weighing less than 1000 grams at birth.

Studietyp

Interventionell

Inskrivning (Faktisk)

1011

Fas

  • Fas 3

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Rocourt, Belgien, B-4000
        • CHC St. Vincent
    • District of Columbia
      • Washington, District of Columbia, Förenta staterna, 20037
        • The George Washington University Hospital
      • Washington, District of Columbia, Förenta staterna, 20007
        • Georgetown University Children's Medical Center
    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02215
        • Beth Israel Deaconess Medical Center (Bidmc)
      • Boston, Massachusetts, Förenta staterna, 02111
        • Tufts University Medical Center
    • New Jersey
      • Voorhees, New Jersey, Förenta staterna, 08043
        • Virtua West Jersey Hospital
    • New York
      • Brooklyn, New York, Förenta staterna, 11203
        • Kings County Hospital
      • Brooklyn, New York, Förenta staterna, 11023
        • SUNY Downstate Medical Center
      • Brooklyn, New York, Förenta staterna, 11355
        • New York Hospital Queens
      • Jamaica, New York, Förenta staterna, 11432
        • Queens Hospital Center
      • New York, New York, Förenta staterna, 11212
        • Brookdale University Hospital & Medical Center
      • Stony Brook, New York, Förenta staterna, 11794-8111
        • Stony Brook University Medical Center
    • Pennsylvania
      • Philadelphia, Pennsylvania, Förenta staterna, 19104
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, Förenta staterna, 19035
        • Pennsylvania Hospital/U. of Pennsylvania
    • Utah
      • Salt Lake City, Utah, Förenta staterna, 84158-1289
        • University of Utah
      • Dublin, Irland
        • National Maternity Hospital
      • Dublin, Irland
        • Coombe Women's Hospital
    • Cork
      • Wilton, Cork, Irland
        • Cork University Maternity Hospital
    • Manitoba
      • Winnipeg, Manitoba, Kanada
        • Winnipeg Health Sciences Centre
      • Winnipeg, Manitoba, Kanada, R3E 0L8
        • St. Boniface General Hospital/University of Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Kanada
        • IWK Health Centre
    • Ontario
      • Hamilton, Ontario, Kanada, L8S 4J9
        • McMaster University
      • Ottawa, Ontario, Kanada, K1H 8L1
        • Children's Hospital of Eastern Ontario
      • Ottawa, Ontario, Kanada, K1H 8L6
        • The Ottawa Hospital General Campus
      • Toronto, Ontario, Kanada
        • Hospital for Sick Children
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada
        • Royal University Hospital
      • Groningen, Nederländerna, 9700 RB
        • University Medical Center Groningen/Beatrix Children's Hosp
      • Zwolle, Nederländerna, 8000 GK
        • Princess Amalia Dept of Pediatrics, Isala Clinics
      • Doha, Qatar
        • Hamad Medical Corporation
      • Singapore, Singapore, 229899
        • KK Women's and Children's Hospital
      • Leicester, Storbritannien, LE1 6TP
        • University of Leicester
      • London, Storbritannien, W2 1NY
        • St. Mary's Hospital
    • Northern Ireland
      • Belfast, Northern Ireland, Storbritannien, BT12 6BB
        • Royal Maternity Hospital
      • Stockholm, Sverige, S-171 76
        • Karolinska University Hospital/Astrid Lingrenn's Children's Hospital
      • Feldkirch, Österrike, 6800
        • LKH Feldkirch

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

Inte äldre än 4 veckor (Barn)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Birth weight <1000 gm
  • Gestational age <30 completed weeks
  • Intention to manage the infant with non-invasive respiratory support (i.e. no endotracheal tube), where either:

    • the infant is within the first 7 days of life and has never been intubated or has received less than 24 hours of total cumulative intubated respiratory support;
    • the infant is within the first 28 days of life, has been managed with intubated respiratory support for 24 hours or more and is a candidate for extubation followed by non-invasive respiratory support.

Exclusion Criteria:

  • Considered non-viable by clinician (decision not to administer effective therapies)
  • Life-threatening congenital abnormalities including congenital heart disease (excluding patent ductus arteriosis)
  • Infants known to require surgical treatment
  • Abnormalities of the upper and lower airways
  • Neuromuscular disorders
  • Infants who are >28 days old and continue to require mechanical ventilation with an endotracheal tube

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: A
Non-invasive respiratory support via nasal intermittent positive pressure ventilation
Deliver non-invasive respiratory support via ventilator with NIPPV device
Aktiv komparator: B
Non-invasive respiratory support via nasal Continuous Positive Airway Pressure
Deliver non-invasive respiratory support via ventilator with nCPAP device

Vad mäter studien?

Primära resultatmått

Resultatmått
Tidsram
Composite of survival to 36 weeks gestational age, free of moderate-severe bronchopulmonary dysplasia
Tidsram: 36 weeks gestational age
36 weeks gestational age

Sekundära resultatmått

Resultatmått
Tidsram
Alla orsakar dödlighet vid 36 veckors graviditetsålder
Tidsram: 36 veckors graviditetsålder
36 veckors graviditetsålder
retinopati av prematuritet
Tidsram: släppa hem
släppa hem
All cause mortality before first discharge home
Tidsram: first discharge home
first discharge home
ultrasonographic evidence of brain injury
Tidsram: 36 weeks gestional age
36 weeks gestional age
necrotizing enterocolitis
Tidsram: 36 weeks gestational age
36 weeks gestational age
growth
Tidsram: discharge home
discharge home
time to establish full feeds
Tidsram: discharge home
discharge home
nosocomial infections
Tidsram: discharge home
discharge home
need for re-intubation
Tidsram: 36 weeks gestational age
36 weeks gestational age
time on supplemental oxygen
Tidsram: discharge home
discharge home
duration of positive pressure respiratory support
Tidsram: discharge home
discharge home
comparison of synchronized and non-synchronized NIPPV
Tidsram: discharge home
discharge home
bronchopulmonary dysplasia
Tidsram: 36 weeks gestational age
36 weeks gestational age
air leak syndromes
Tidsram: 36 weeks gestational age
36 weeks gestational age
nasal trauma
Tidsram: discharge home
discharge home

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studiestol: Haresh Kirpalani, MD, MSc, Hamilton Health Sciences Corporation
  • Studierektor: Brigitte Lemyre, MD, Children's Hospital of Eastern Ontario
  • Studierektor: Aaron Chiu, MD, St. Boniface Hospital
  • Studierektor: David Millar, MD, Royal Maternity Hospital, Belfast
  • Studierektor: Robin S Roberts, MTech, Hamilton Health Sciences/McMaster University
  • Studierektor: Bradley Yoder, MD, University of Utah
  • Studierektor: Peter H Dijk, MD, PhD, University Medical Centrum Groningen

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 april 2007

Primärt slutförande (Faktisk)

1 augusti 2011

Avslutad studie (Faktisk)

1 december 2011

Studieregistreringsdatum

Först inskickad

7 februari 2007

Först inskickad som uppfyllde QC-kriterierna

8 februari 2007

Första postat (Uppskatta)

9 februari 2007

Uppdateringar av studier

Senaste uppdatering publicerad (Uppskatta)

5 december 2014

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 december 2014

Senast verifierad

1 december 2014

Mer information

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera